Skip to main content
SpringerLink
Log in

HBV/HCV Co-infection and Mixed Cryoglobulinemia

  • Chapter
  • First Online:
HCV Infection and Cryoglobulinemia

  • 676 Accesses

Abstract

It is estimated that 35–50 million people are chronically co-infected with HBV and HCV worldwide. In mono-infected patients, both viruses have been associated with numerous extrahepatic manifestations. Among these, polyarteritis nodosa and glomerulonephritis are most frequently documented in HBV and mixed cryoglobulinemia (MC) in HCV cases. With the exception of anecdotal observations, there are no data regarding MC in individuals with dual chronic infection by HCV and overt or occult HBV. Based on the interplay between the two viruses in infected patients, extrahepatic manifestations can be attributed to one or the other virus, in either a dominant or co-dominant role; however, this relationship may change over time, either spontaneously or as a consequence of therapy. Furthermore, equal or at least synergistic roles of HBV and HCV in triggering the production of cryoglobulins in some patients with overt or occult co-infection cannot be excluded. An attempt at viral eradication or sustained suppression of viral replication is indicated in all patients with cryoglobulinemic syndrome and HBV/HCV co-infection, after an accurate assessment of the activity/severity of the vasculitis and the underlying liver disease. Furthermore, due to the variable virological patterns, a careful longitudinal evaluation of the viremia levels of both HBV and HCV is mandatory prior to the initiation of antiviral therapy, in order to assess the patient’s current virological status and thereby determine the most appropriate therapeutic regimen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chu CJ, Lee SD (2008) Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment. J Gastroenterol Hepatol 23:512–520

    Article  PubMed  Google Scholar 

  2. Pontisso P, Ruvoletto MG, Fattovich G et al (1993) Clinical and virological profiles in patients with multiple hepatitis infections. Gastroenterology 105:1529–1533

    Article  PubMed  CAS  Google Scholar 

  3. Sato S, Fujiyama S, Tanaka M et al (1994) Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 21:159–166

    Article  PubMed  CAS  Google Scholar 

  4. Crespo J, Lozano JL, de la Cruz F et al (1994) Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am J Gastroenterol 89:1147–1151

    PubMed  CAS  Google Scholar 

  5. Alberti A, Pontisso P, Chemello L et al (1995) The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J Hepatol 22(Suppl 1):S38–S41

    Google Scholar 

  6. Zarski JP, Bohn B, Bastie A et al (1998) Characteristic of patients with dual infection by hepatitis B and C viruses. J Hepatol 28:27–33

    Article  PubMed  CAS  Google Scholar 

  7. Raimondo G, Brunetto MR, Pontisso P et al (2006) Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology 43:100–107

    Article  PubMed  Google Scholar 

  8. Lavanchy D (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11:97–107

    Article  PubMed  CAS  Google Scholar 

  9. Gaeta GB, Stornaiuolo G, Precone DF et al (2003) Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol 39:1036–1041

    Article  PubMed  Google Scholar 

  10. Sagnelli E, Pasquale G, Coppola N et al (2004) Influence of chronic co-infection with hepatitis B and C virus on liver histology. Infection 32:144–148

    Article  PubMed  CAS  Google Scholar 

  11. Lee LP, Dai CY, Chuang WL et al (2007) Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C-coinfected patients. J Gastroenterol Hepatol 22:515–517

    Article  PubMed  Google Scholar 

  12. Fattovich G, Tagger A, Brollo L et al (1991) Hepatitis virus infection in chronic hepatitis B virus carriers. J Infect Dis 163:400–402

    Article  PubMed  CAS  Google Scholar 

  13. Simonetti RG, Cammà C, Fiorello F et al (1992) Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 116:97–102

    Article  PubMed  CAS  Google Scholar 

  14. Benvegnù L, Fattovich G, Noventa F et al (1994) Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. Cancer 74:2442–2448

    Article  PubMed  Google Scholar 

  15. Liaw YF (1995) Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 22:1101–1108

    PubMed  CAS  Google Scholar 

  16. Shih CM, Lo SJ, Miyamura T et al (1993) Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in Hu-H7 cells. J Virol 67:5823–5832

    PubMed  CAS  Google Scholar 

  17. Shih CM, Chen CM, Chen SY, Lee YH (1995) Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol 69:1160–1171

    PubMed  CAS  Google Scholar 

  18. Schuttler CG, Fiedler N, Schmidt K et al (2002) Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 37:855–862

    Article  PubMed  CAS  Google Scholar 

  19. Chen SY, Kao CF, Chen CM et al (2003) Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem 278:591–607

    Article  PubMed  CAS  Google Scholar 

  20. Sheen IS, Liaw YF, Chu CM, Pao CC (1992) Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. J Infect Dis 165:831–834

    Article  PubMed  CAS  Google Scholar 

  21. Chu CM, Yeh CT, Liaw YF (1998) Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection. J Clin Microbiol 36:2084–2086

    PubMed  CAS  Google Scholar 

  22. Jardi R, Rodriguez F, Buti M et al (2001) Role of hepatitis B, C and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 34:404–410

    Article  PubMed  CAS  Google Scholar 

  23. Squadrito G, Orlando ME, Pollicino T et al (2002) Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. Am J Gastroenterol 97:1518–1523

    Article  PubMed  Google Scholar 

  24. Sagnelli E, Coppola N, Scolastico C et al (2000) Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 32:1106–1110

    Article  PubMed  CAS  Google Scholar 

  25. Ohkawa K, Hayashi N, Yuki N et al (1994) Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. J Hepatol 21:509–514

    Article  PubMed  CAS  Google Scholar 

  26. Ohkawa K, Hayashi N, Yuki N et al (1995) Long-term follow up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses. J Med Virol 46:258–264

    Article  PubMed  CAS  Google Scholar 

  27. Raimondo G, Pollicino T, Cacciola I, Squadrito G (2007) Occult hepatitis B virus infection. J Hepatol 46:160–170

    Article  PubMed  Google Scholar 

  28. Ganem D, Prince AM (2004) Hepatitis B virus infection – natural history and clinical consequences. N Engl J Med 350:1118–1129

    Article  PubMed  CAS  Google Scholar 

  29. Zoulim F (2005) New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol 42:302–308

    Article  PubMed  Google Scholar 

  30. Yamamoto K, Horikita M, Tsuda F et al (1994) Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 68:2671–2676

    PubMed  CAS  Google Scholar 

  31. Kreutz C (2002) Molecular, immunological and clinical properties of mutated hepatitis B viruses. J Cell Mol Med 6:113–143

    Article  PubMed  CAS  Google Scholar 

  32. Jeantet D, Chemin I, Mandrand B et al (2004) Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. J Med Virol 73:508–515

    Article  PubMed  CAS  Google Scholar 

  33. Chaudhuri V, Tayal R, Nayak B et al (2004) Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 127:1356–1371

    Article  PubMed  CAS  Google Scholar 

  34. Pollicino T, Raffa G, Costantino L et al (2007) Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 45:277–285

    Article  PubMed  CAS  Google Scholar 

  35. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV (1996) The hepatitis B virus persists for decades after patients’ recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 10:1104–1108

    Article  Google Scholar 

  36. Guidotti LG, Rochford R, Chung J et al (1999) Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825–829

    Article  PubMed  CAS  Google Scholar 

  37. Cacciola I, Pollicino T, Squadrito G et al (1999) Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 341:22–26

    Article  PubMed  CAS  Google Scholar 

  38. Torbenson M, Thomas DL (2002) Occult hepatitis B. Lancet Infect Dis 2:479–486

    Article  PubMed  Google Scholar 

  39. Liu CJ, Lo SC, Kao JH et al (2006) Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol 44:39–46

    Article  PubMed  Google Scholar 

  40. Chazouilleres O, Mamish D, Kim M et al (1994) Occult hepatitis B virus as source of infection in liver transplant recipients. Lancet 343:142–146

    Article  PubMed  CAS  Google Scholar 

  41. Wachs ME, Amend WJ, Ascher NL et al (1995) The risk of transmission of hepatitis B from HBsAg(−), HBcAb(+), HBIgM(−) organ donors. Transplantation 59:230–234

    PubMed  CAS  Google Scholar 

  42. Lok ASF, Liang RHS, Chiu EKW et al (1991) Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology 100:182–188

    PubMed  CAS  Google Scholar 

  43. Dhedin N, Douvin C, Kuentz M et al (1998) Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. Transplantation 66:616–619

    Article  PubMed  CAS  Google Scholar 

  44. Abdelmalek MF, Pasha TM, Zein NN et al (2003) Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure. Liver Transpl 9:1253–1257

    PubMed  Google Scholar 

  45. Onozawa M, Hashino S, Izumiyama K et al (2005) Pro­gressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hemato­poietic stem cell transplantation in patients with previous hepatitis B virus infection. Transplantation 79:616–619

    Article  PubMed  Google Scholar 

  46. Zhang YY, Hansson BG, Kuo LS et al (1993) Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg. Hepatology 17:538–544

    Article  PubMed  CAS  Google Scholar 

  47. Sagnelli E, Coppola N, Scolastico C et al (2001) HCV genotype and “silent” HBV coinfection: two main risk factors for a more severe liver disease. J Med Virol 64:350–355

    Article  PubMed  CAS  Google Scholar 

  48. Chemin I, Trepo C (2005) Clinical impact of occult HBV infections. J Clin Virol 34(Suppl 1):S15–S21

    Article  PubMed  Google Scholar 

  49. Yu MC, Yuan JM, Ross RK, Govindarajan S (1997) Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California. Hepatology 25:226–228

    Article  PubMed  CAS  Google Scholar 

  50. Brechot C (2004) Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127(Suppl 1):S56–S61

    Article  PubMed  CAS  Google Scholar 

  51. Pollicino T, Squadrito G, Cerenzia G et al (2004) Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126:102–110

    Article  PubMed  CAS  Google Scholar 

  52. Squadrito G, Pollicino T, Cacciola I et al (2006) Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. Cancer 106:1326–1330

    Article  PubMed  Google Scholar 

  53. Gocke DJ, Hsu K, Morgan C et al (1970) Association between polyarteritis and Australia antigen. Lancet 296:1149–1153

    Article  Google Scholar 

  54. Han SH (2004) Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis 8:403–418

    Article  PubMed  Google Scholar 

  55. Jori GP, Buonanno G (1972) Chronic hepatitis and cirrhosis of the liver in cryoglobulinemia. Gut 13:610–613

    Article  PubMed  CAS  Google Scholar 

  56. Florin-Christensen A, Roux MEB, Arana RM (1974) Cryoglobulins in acute and chronic liver diseases. Clin Exp Immunol 16:599–605

    PubMed  CAS  Google Scholar 

  57. Levo Y, Gorevic PD, Kassab HJ et al (1977) Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 296:1501–1504

    Article  PubMed  CAS  Google Scholar 

  58. Dienstag JL, Wands JR, Isselbacher KJ (1977) Hepatitis B and essential mixed cryoglobulinemia. N Engl J Med 297:946–947

    PubMed  CAS  Google Scholar 

  59. Popp JW Jr, Dienstag JL, Wands JR, Bloch KJ (1980) Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med 92:379–383

    Article  PubMed  Google Scholar 

  60. Galli M (1991) Cryoglobulinaemia and serological markers of hepatitis viruses. Lancet 338:758–759

    Article  PubMed  CAS  Google Scholar 

  61. Galli M, Monti G, Invernizzi F et al (1992) Hepatitis B virus-related markers in secondary and in essential mixed cryoglobulinemias: a multicenter study of 596 cases. The Italian group for the study of crioglobulinemias (GISC). Ann Ital Med Int 7:209–214

    PubMed  CAS  Google Scholar 

  62. Galli M (1995) Viruses and cryoglobulinemia. Clin Exp Rheumatol 13(Suppl 13):S63–S70

    PubMed  Google Scholar 

  63. Della Rossa A, Tavoni A, Lorefice P et al (2000) HBV and HCV infection, polyarteritis nodosa and mixed cryoglobulinemia: a case report. Clin Rheumatol 19:502–504

    Article  PubMed  CAS  Google Scholar 

  64. Garcia de La Peña Lefebvre P, Mouthon L, Cohen P et al (2001) Polyarteritis nodosa and mixed cryoglobulinaemia related to hepatitis B and C virus coinfection. Ann Rheum Dis 60:1068–1069

    Article  Google Scholar 

  65. Ferri C, Zignego AL, Pileri SA (2002) Cryoglobulins. J Clin Pathol 55:4–13

    Article  PubMed  CAS  Google Scholar 

  66. Ferri C, Mascia MT (2006) Cryoglobulinemic vasculitis. Curr Opin Rheumatol 18:54–63

    PubMed  Google Scholar 

  67. Coffin CS, Terrault NA (2009) Management of patients co-infected with HBV and HCV. Expert Rev Anti Infect Ther 7:549–558

    Article  PubMed  CAS  Google Scholar 

  68. Potthoff A, Wedemeyer H, Boecher WO et al (2008) The HEP-NET B/C co-infection trial: a prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection. J Hepatol 49:688–694

    Article  PubMed  CAS  Google Scholar 

  69. Liu CJ, Chuang WL, Lee CM et al (2009) Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology 136:496–504

    Article  PubMed  CAS  Google Scholar 

  70. Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology 45:507–539

    Article  PubMed  CAS  Google Scholar 

  71. Carosi G, Rizzetto M (2008) Treatment of chronic hepatitis B: recommendations from an Italian workshop. Dig Liver Dis 40:603–617

    Article  PubMed  CAS  Google Scholar 

  72. European Association for the Study of the Liver (2009) EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 50:227–242

    Article  Google Scholar 

  73. Lok AS, McMahon BJ (2009) Chronic hepatitis B: update 2009. Hepatology 50:661–662

    Article  PubMed  Google Scholar 

  74. Ghany MG, Strader DB, Thomas DL, Seeff LB (2009) Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49:1335–1374

    Article  PubMed  CAS  Google Scholar 

  75. Italian Association for the Study of the Liver; Italian Society of Infectious, Tropical Diseases; Italian Society for the Study of Sexually Transmitted Diseases (2009) Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST expert opinion meeting. Dig Liver Dis 42:81–91

    Google Scholar 

  76. European Association for the Study of the Liver (2011) EASL clinical practice guidelines: management of hepatitis C infection. J Hepatol 55:245–64

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Sciences “Luigi Sacco”, Section of Infectious and Tropical Diseases, Università di Milano, Milan, Italy

    Massimo Galli & Salvatore Sollima

Authors
  1. Massimo Galli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Salvatore Sollima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Massimo Galli .

Editor information

Editors and Affiliations

  1. , Department of Internal Medicine and Clin, University of Bari, Piazza Giulio Cesare 11, Bari, 70124, Italy

    Franco Dammacco

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Italia

About this chapter

Cite this chapter

Galli, M., Sollima, S. (2012). HBV/HCV Co-infection and Mixed Cryoglobulinemia. In: Dammacco, F. (eds) HCV Infection and Cryoglobulinemia. Springer, Milano. https://doi.org/10.1007/978-88-470-1705-4_28

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1705-4_28

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1704-7

  • Online ISBN: 978-88-470-1705-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation